Login

Healthcare

00:00:00
Alligator Bioscience at the ØU Lifescience Investor Conference, November 22, 2023 - Søren Bregenholt , CEO, Alligator Bioscience
00:00:00
Alligator meets primary endpoint with CD40 agonist in pancreatic cancer - Søren Bregenholt , CEO, Alligator Bioscience
00:00:00
Alligator Bioscience restructuring as part of long-term strategy - Søren Bregenholt , CEO, Alligator Bioscience
00:00:00
Alligator Bioscience - CEO Statement - Søren Bregenholt , CEO, Alligator Bioscience
00:00:00
Allergy Therapeutics - Nick Wykeman, CFO
00:00:00
Allergy Therapeutics says US preparations are underway which include two pivotal trials - Manuel Llobert, CEO, Allergy Therapeutics
00:00:00
Allergy Therapeutics to sniff out more M&A deals - Manuel Llobert, CEO, Allergy Therapeutics
00:00:00
Alimera Sciences - RICK EISWIRTH President and Chief Executive Officer, Alimera Sciences Inc
00:00:00
Akers Biosciences Inc to be cash generative in second half - Raymond Akers, Executive chairman of Akers Biosciences Inc
00:00:00
Akers Biosciences : It’s now all about execution - Ray Akers, co-founder and executive chairman of Akers Biosciences
00:10:00
Executive interview with Basilea Pharmaceutica | David Veitch, CHIEF EXECUTIVE OFFICER, BASILEA PHARMACEUTICA INTERNATIONAL LTD
00:10:00
2020 will be a pivotal year for Arcturus Therapeutics as a corporation | Joseph E. Payne, CHIEF EXECUTIVE OFFICER, ARCTURUS THERAPEUTICS LTD
00:10:00
Creating the Next Wave of Cancer Treatments for Patients | Athena Countouriotis, M.D. Chairperson, Avenzo Therapeutics
00:10:00
Executive Highlights Edwina Payne of Avanos Medical | JOSEPH F. WOODY, CEO OF AVANOS MEDICAL INC
00:10:00
AVACTA's Chief Scientific Officer, Dr. Fiona McLaughlin | Alastair Smith, CEO, AVACTA THERAPEUTICS.
00:10:00
An Exploration into Autoimmunity | Molly Murray_CAE, CEO OF AUTOIMMUNE ASSOCIATION

© 2026 Nehu